Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome
作者： Yohannes W. Woldeamanuel , Meabh O'Hare , Danielle D. DeSouza , Robert P. Cowan
DOI: 10.1212/WNL.0000000000003230
关键词:
摘要: Transient headache exacerbation during IV dihydroergotamine (DHE) therapy of migraine may prompt clinicians to prematurely discontinue DHE therapy, potentially depriving patients the full benefit infusion. In a recent Neurology® article, Eller et al. evaluated whether or not worsening infusion was associated with suboptimal medium-term outcomes.
sci-hub.se 参考文章(9)
Nathaniel M. Schuster, Sarah Vollbracht, Alan M. Rapoport, Emerging treatments for the primary headache disorders. Neurological Sciences. ,vol. 36, pp. 109- 113 ,(2015) , 10.1007/S10072-015-2133-1
Jeroan J. Allison, Terry C. Wall, Claire M. Spettell, Jaimee Calhoun, Crayton A. Fargason, Richard W. Kobylinski, Robert Farmer, Catarina Kiefe, The art and science of chart review. The Joint Commission journal on quality improvement. ,vol. 26, pp. 115- 136 ,(2000) , 10.1016/S1070-3241(00)26009-4
A. J. Nagy, S. Gandhi, R. Bhola, P. J. Goadsby, Intravenous dihydroergotamine for inpatient management of refractory primary headaches Neurology. ,vol. 77, pp. 1827- 1832 ,(2011) , 10.1212/WNL.0B013E3182377DBB
Rami Burstein, Moshe Jakubowski, Dan Levy, Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors Pain. ,vol. 115, pp. 21- 28 ,(2005) , 10.1016/J.PAIN.2005.01.027
Stewart J. Tepper, Orally inhaled dihydroergotamine: a review. Headache. ,vol. 53, pp. 43- 53 ,(2013) , 10.1111/HEAD.12184
Andrew Worster, Ted Haines, Advanced Statistics: Understanding Medical Record Review (MRR) Studies Academic Emergency Medicine. ,vol. 11, pp. 187- 192 ,(2004) , 10.1111/J.1553-2712.2004.TB01433.X
N. H. Raskin, Repetitive intravenous dihydroergotamine as therapy for intractable migraine Neurology. ,vol. 36, pp. 995- 995 ,(1986) , 10.1212/WNL.36.7.995
Michael Eller, Amy A. Gelfand, Nina Y. Riggins, Stephen Shiboski, Christoph Schankin, Peter J. Goadsby, Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome Neurology. ,vol. 86, pp. 856- 859 ,(2016) , 10.1212/WNL.0000000000002406
, The International Classification of Headache Disorders, 3rd edition (beta version) Cephalalgia. ,vol. 33, pp. 629- 808 ,(2013) , 10.1177/0333102413485658